Search

You searched for "Supporting"

2038 results found
Ophthalmology journal cover image.

Two-year GATHER2 data: anatomical gains, functional questions for avacincaptad pegol in geographic atrophy

5 August 2026 | | EYE - General
Geographic atrophy (GA) secondary to age-related macular degeneration (AMD) remains a leading cause of irreversible central vision loss, and complement dysregulation has long been implicated in its pathogenesis. In 2023, the US FDA approved the first two GA therapies, both...

A new apprenticeship to train specialists in children’s eyecare and vision problems

4 February 2025 | | EYE - Paediatrics
A pioneering apprenticeship has launched that will create new opportunities for people to train as eyecare specialists while helping to tackle growing vision problems in children and adults across England. For the first time, aspiring orthoptists can now train through...

The Opening of CooperVision’s new global innovation hub, The Vision Centre

9 October 2026 | industry
Last month, CooperVision officially opened The Vision Centre, its new global innovation and R&D hub, at Adanac Park, Nursling, Southampton. The opening was attended by Al White, President & CEO, Cooper Companies; Jerry Warner, President of CooperVision; Debbie Olive, Global...

New Flying Eye Hospital takes to the skies for its first programme

1 December 2016 | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
In June of this year, international eye care charity Orbis launched their new Flying Eye Hospital, a powerful tool helping the medical community combat preventable blindness through sustainable methods. On board an MD-10 aircraft, a fully accredited ophthalmic facility can...

Addressing childhood blindness in sub-Saharan Africa

2 August 2024 | | EYE - Paediatrics, EYE - Strabismus
In this article, the authors explore paediatric ophthalmology subspecialist fellowship training in African nations south of the Sahara. Until recently, most African ophthalmologists who wished to pursue a subspecialty ophthalmology training fellowship had to go abroad. There is a huge...

Light in darkness – manual small incision cataract surgery in India

1 August 2017 | | EYE - Cataract, EYE - Refractive
Cataract has been documented to be the most significant cause of bilateral blindness in India, where vision <20/200 in the better eye on presentation is defined as blindness [1,2]. Estimation of blindness in India by the World Health Organization (WHO)...

Screening for Sickle Cell Retinopathy (SCR): Why we do wide-field imaging, OCT/OCT-A for SCR – Newcastle upon Tyne Hospitals NHS Foundation Trust

1 June 2022 | | EYE - Vitreo-Retinal, EYE - Imaging
I have been working in ophthalmology for over five years as a photographer and research co-ordinator, and it is fascinating, rewarding, and interesting to learn all about the different diseases associated with the eye. One condition that has been a...

An Inconvenient Truth: Pete’s hidden curriculum Part 4

5 June 2023 | | EYE - General
“What gets us into trouble is not what we don’t know. It’s what we know for sure that just ain’t so.” The above is a quote attributed to Mark Twain from the 2006 documentary, An Inconvenient Truth, which follows Al...

Only fools and doctors

2 April 2025 | | EYE - General
“Alright, this is where our future lies Rodney. Second hand motors. This time next year we’ll be millionaires.” The above is the well-known quote by the happy-go-lucky Del Boy from the famous British sitcom, Only Fools and Horses, forever on...

100% Optical and Optrafair organisers join forces

27 July 2020
From now on there will be one major annual exhibition, 100% Optical at London’s ExCeL exhibition centre, which has full industry support from the FMO and other major optical bodies.

Overcoming sight impairment for the Race Across the World!

22 March 2023 | uveitis, travel
RNIB’s Tricia travels the world and takes her message that "sight loss doesn’t stop you doing anything" to BBC One.

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

29 March 2023 | glaucoma
Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.